ClinicalTrials.gg
RecruitingNCT07791693Updated Nov 18, 2026

Effects of Explosive Plyometric Training Versus Thera-Band Power Training on Sprint Swimming Performance

An interventional study of Closed-Chain Explosive Plyometric Training and Open-Chain TheraBand-Based Power Training in Sports Physical Therapy, sponsored by Riphah International University. Recruiting at 1 site in Pakistan. Open to male participants aged 17 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

Updated Nov 18, 2026Now RecruitingFirst site in Pakistan+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
17 Years to 25 Years
Sex
Male
01

Study summary

This randomized controlled trial will compare the effects of upper-limb explosive plyometric training and TheraBand-based power training on sprint swimming performance in competitive swimmers. Participants will be randomly allocated to either an explosive plyometric training group or a TheraBand-based power training group. Both groups will continue their routine aquatic training while completing their assigned dry-land training program for eight weeks. Outcomes including 50-meter freestyle performance, Medicine Ball Throw Test performance, and 15-meter sprint time will be assessed at baseline and after completion of the intervention. The study aims to determine which upper-limb training approach is more effective for improving sprint swimming performance.

Read the detailed description

The study aims to compare the effects of upper-limb explosive plyometric training and TheraBand-based power training on sprint swimming performance in competitive swimmers. The objectives are to compare the effects of both training approaches on 50-meter freestyle swimming performance, upper-limb power measured by the Medicine Ball Throw Test, and 15-meter sprint tim

02

Conditions studied

  • Sports Physical Therapy

Keywords

  • Upper-Limb Plyometric Training
  • TheraBand Power Training
  • Dry-Land Training
  • Upper-Limb Power
  • 50-Meter Freestyle
  • Medicine Ball Throw Test
  • Swimming Performance
  • 15-Meter Sprint Time
03

In context

Lead sponsor

Riphah International University is the lead sponsor of 2,200 studies on the registry; 650 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
17 Years to 25 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male competitive swimmers.
  • At least 2 years of swimming training experience.
  • Training at least 3 sessions per week.
  • Willing to participate in the study and provide .

Exclusion criteria

Exclusion Criteria

  • Musculoskeletal injury within the past 3 months.
  • Neurological disorders.
  • Cardiovascular disorders.
  • Current participation in structured resistance or plyometric training programs outside the study.
  • to exercise or swimming.
  • Non-compliance with training sessions.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Closed-Chain Explosive Plyometric Training

    Participants will perform a structured upper-limb explosive plyometric training program three times per week for eight weeks in addition to their routine aquatic training. The program will include explosive push-ups, medicine ball chest passes, overhead medicine ball throws, plyometric push-ups, and other upper-limb power drills using progressive overload.

    Other: Closed-Chain Explosive Plyometric Training

  • Active comparator
    Open-Chain TheraBand-Based Power Training

    Participants will perform a structured upper-limb power training program using progressive TheraBand resistance three times per week for eight weeks in addition to their routine aquatic training. Exercises will target the shoulder girdle, upper arm, and scapular stabilizers through controlled movements related to freestyle swimming. Resistance will be progressively increased according to participants' performance and tolerance.

    Other: Open-Chain TheraBand-Based Power Training

Interventions

  • OtherClosed-Chain Explosive Plyometric Training

    Participants will perform a structured upper-limb explosive plyometric training program three times per week for eight weeks in addition to their routine aquatic training. The program will include explosive push-ups, medicine ball chest passes, overhead medicine ball throws, plyometric push-ups, and other upper-limb power drills using progressive overload.

  • OtherOpen-Chain TheraBand-Based Power Training

    Participants will perform a structured upper-limb power training program using progressive TheraBand resistance three times per week for eight weeks in addition to their routine aquatic training. Exercises will target the shoulder girdle, upper arm, and scapular stabilizers through controlled movements related to freestyle swimming. Resistance will be progressively increased according to participants' performance and tolerance.

06

What researchers measure

Primary outcomes

  1. 50-Meter Freestyle Time

    Time in seconds required to complete the 50-meter freestyle time trial, measured at baseline and after completion of the 8-week intervention. Lower time indicates better sprint swimming performance.

    Time frame: Baseline and Week 8

  2. 15-Meter Sprint Time

    Time in seconds required to complete the 15-meter sprint, measured at baseline and after completion of the 8-week intervention. Lower time indicates better sprint start performance.

    Time frame: Baseline and Week 8

  3. Medicine Ball Throw Distance

    Distance achieved in the Medicine Ball Throw Test, measured at baseline and after completion of the 8-week intervention. Greater distance indicates greater upper-limb power.

    Time frame: Baseline and Week 8

07

Study locations

1 of 1 sites recruiting
  • Jacaranda family club Dha2
    Islamabad, Federal 45730, Pakistan
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Nov 2026 (actual). Primary completion is estimated for Jan 2027, 2 months after the start.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 18, 2026: start Sep 2026 → Nov 2026, primary completion Nov 2026 → Jan 2027 and completion Nov 2026 → Nov 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 25, 2026
First posted
Aug 28, 2026
StartActual
Nov 4, 2026was Sep 2026
Primary completionEst.
Jan 2027was Nov 2026
CompletionEst.
Nov 2027was Nov 2026
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 18, 2026
Sites
1 site added — first site in Pakistan
Show site
  • Jacaranda family club Dha2 · Islamabad, Pakistan
Nov 18, 2026
Start date
Sep 2026→Nov 4, 2026 (actual)
Nov 18, 2026
Primary completion
Nov 2026→Jan 2027
Nov 18, 2026
Study completion
Nov 2026→Nov 2027
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in Pakistan
    Show site
    • Jacaranda family club Dha2 · Islamabad, Pakistan
    Start date Sep 2026→Nov 4, 2026 (now actual)
    Primary completion Nov 2026→Jan 2027
    Study completion Nov 2026→Nov 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07791693
Responsible party
Sponsor
First posted
Aug 28, 2026
Start date
Nov 4, 2026
Primary completion
Jan 2027 (estimated)
Completion
Nov 2027 (estimated)
Last update
Nov 18, 2026

Study contacts

Zobia Naseem, MS-SPT
Contact
zobia.naseem@riphah.edu.pk
+923321963584 ext. 92 332 1963584
Zobia Naseem, MS-SPT
principal investigator · Riphah International University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion